Page last updated: 2024-10-22

albendazole and Chemical and Drug Induced Liver Injury, Chronic

albendazole has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 1 studies

Chemical and Drug Induced Liver Injury, Chronic: Liver disease lasting six months or more, caused by an adverse effect of a drug or chemical. The adverse effect may be caused by drugs, drug metabolites, chemicals from the environment, or an idiosyncratic response.

Research Excerpts

ExcerptRelevanceReference
"The treatment with albendazole was mostly given for liver hydatid cysts or empirically."2.72Albendazole-Induced Liver Injury. ( Dumitrascu, DL; Piloiu, C, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Piloiu, C1
Dumitrascu, DL1

Reviews

1 review available for albendazole and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
Albendazole-Induced Liver Injury.
    American journal of therapeutics, 2021, Feb-03, Volume: 28, Issue:3

    Topics: Albendazole; Anthelmintics; Chemical and Drug Induced Liver Injury, Chronic; Echinococcosis, Hepatic

2021